Medrad Announces First Use of Cotavance® Catheter in Research
- Cardio
- 19/08/2011
Medrad, a business of Bayer HealthCare AG, today announced first use of the next-generation Cotavance® catheter in a research setting with the start of patient enrollment in the ev3 DEFINITIVE™ AR...
READ MORE